Latest News
& Press Releases
Browse the latest news from BioSpace, and press releases from around the industry. Want to filter by date, keyword, and more? Search here.
TOP STORIES
Amicus Therapeutics is launching a next-generation genetic medicine company called Caritas Therapeutics, Inc. through a merger deal with ARYA Sciences Acquisition Corp IV.
Pfizer reported three cases of muscle weakness, two of which involved inflammation of the heart (myocarditis).
Biomolecular condensates could hold the key to unlocking a number of neurological diseases that have baffled researchers the longest.
These life sciences companies are falling into some cold, hard investment cash.
Kytopen has seen an influx of cash of the past few months. Most recently, the biotech raised a large chunk of money in its Series A funding round, which was announced on Tuesday.
Celyad is focusing on advancing chimeric antigen receptor T cell (CAR T) therapies.
Anji will use the new funds to advance its two late-stage clinical programs in metabolic disorders and propel its oncology pipeline into the clinic.
Nucleate, the non-profit organization seeking to support future leaders in the life sciences industry, announced its official launch and immediately opened applications to its Activator program.
The Phase II trial, VLA150202, evaluated the safety and immunogenicity of VLA15 on 246 healthy adults aged 18 to 65 years old across the United States.
Sputnik Vaccine’s 91.6% efficacy against the original COVID-19 strain has stood up to peer review in The Lancet. But what’s the controversy, lets’s check it out.
FDA approved ViiV Healthcare’s Cabenuva as the very first once-a-month injection for HIV treatment. But the Research Triangle pharma isn’t satisfied yet.
Biogen agreed to pay $22 million in response to allegations that it violated the False Claims Act, and now, life insurance company Humana is suing Biogen over a similar scheme.